SEC Form 4 · accession 0000899243-17-014577
REGENXBIO Inc. · RGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Tasse
Director
Period of report
May 24, 2017
Accepted (ET)
May 26, 2017 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $18.85 | May 24, 2017 | A | 12,500 | A | — | May 24, 2027 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The option will vest in 12 equal monthly installments following May 24, 2017.
Remarks
EXHIBIT LIST - Exhibit 24 - Power of Attorney for Daniel Tasse.